Our impact on dementia research
Getting access to the best quality data is one of the biggest difficulties facing dementia researchers today. In our first five years, we've worked to break down these barriers by opening up access to detailed datasets.
Our work advances data access and fast-tracks science
DPUK tools and resources are the foundation for a wide range of research studies in dementia.
DPUK resources experimental medicine for dementia
Enabling participation in research
The foundation of multicentre research
Leveraged funding for large-scale studies
New spaces for new ideas
By providing the opportunity for academic and industry scientists to get to together, DPUK's research communities have broken down traditional barriers and nurtured innovative collaborations.
Repurposing the drug libraries
Using the patient-specific cell models derived from DPUK cohorts, a joint research team is investigating the behaviour of drugs developed by AstraZeneca (AZ) to identify new avenues for treatments.
Joining up the dots
DPUK investment has enabled scientists to study the development of brain disease using a type of stem cell derived from the blood samples of cohort study participants.